ADVIA CENTAUR XP RUBELLA G (RUB G) ASSAY N/A 10310283

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2018-10-09 for ADVIA CENTAUR XP RUBELLA G (RUB G) ASSAY N/A 10310283 manufactured by Siemens Healthcare Diagnostics, Inc..

Event Text Entries

[125478874] The cause for the non-reproduced discordant advia centaur xp rubella g (rub g) result obtained on a patient sample cannot be determined. The customer's rubella g calibration and quality control (qc) were acceptable, and the sample dispense well was clear. Pre-analytical factors cannot be ruled out, and variables can affect the quality of the sample, and deviation from recommended best practices can lead to erroneous results. There were no other similar complaints for rubella g reagent lot 068204 on review. Based on the available information, rubella igg lot 068204 is performing as intended. The instruction for use (ifu) under the interpretation of results states the following: "samples with a calculated value of less than 5. 0 iu/ml are considered negative for igg antibodies to rubella virus. " "samples with a calculated value greater than or equal to 5. 0 iu/ml and less than or equal to 9. 9 iu/ml are considered equivocal for igg antibodies to rubella virus. Obtain a new specimen and test using the advia centaur rubella g assay. " "samples with a calculated value greater than or equal to 10. 0 iu/ml are considered positive for igg antibodies to rubella virus. " the instrument is performing within specification. No further evaluation of the device is required.
Patient Sequence No: 1, Text Type: N, H10


[125478875] A false positive advia centaur xp rubella g (rub g) result was obtained on a patient sample, and the result was questioned by the physician based on the patient's negative rubella g test history. A second sample was tested by the customer, and the rubella g result was equivocal. The original sample was retested, and the rubella g result was equivocal. A corrected report was issued by the customer. There are no reports that treatment was altered or prescribed or adverse health consequences due to the positive advia centaur xp rubella igg result.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1219913-2018-00248
MDR Report Key7947990
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2018-10-09
Date of Report2018-10-09
Date of Event2018-09-12
Date Mfgr Received2018-09-21
Device Manufacturer Date2018-03-08
Date Added to Maude2018-10-09
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactSTEPHEN PERRY
Manufacturer Street333 CONEY STREET
Manufacturer CityEAST WALPOLE MA 02032
Manufacturer CountryUS
Manufacturer Postal02032
Manufacturer Phone5086604163
Manufacturer G1SIEMENS HEALTHCARE DIAGNOSTICS, INC.
Manufacturer Street333 CONEY STREET
Manufacturer CityEAST WALPOLE MA 02032
Manufacturer CountryUS
Manufacturer Postal Code02032
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameADVIA CENTAUR XP RUBELLA G (RUB G) ASSAY
Generic NameRUBELLA G IMMUNOASSAY
Product CodeLFX
Date Received2018-10-09
Model NumberN/A
Catalog Number10310283
Lot Number068204
Device Expiration Date2019-03-08
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerSIEMENS HEALTHCARE DIAGNOSTICS, INC.
Manufacturer Address511 BENEDICT AVENUE TARRYTOWN NY 105915097 US 105915097


Patients

Patient NumberTreatmentOutcomeDate
10 2018-10-09

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.